Sabby Management »

Brainstorm Cell Therapeutics call shares owned by Sabby Management

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics call shares owned by Sabby Management from 13F filings

Historical chart of Sabby Management investment in Brainstorm Cell Therapeutics call

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics call held by Sabby Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics call by Sabby Management

Quarter filed Position value Share count Share price at filing
2023-09-30 $61k 3.0k 20.01
2023-06-30 $2.6M 1.3M 2.06
2017-03-31 $299 70k 0.00
2016-03-31 $47 175 0.27

More positions owned by Sabby Management

Ishares Tr Etf Put Option
SPDR S&P 500 Etf Put Option
Ishares Tr Etf (IWM)
SPDR S&P 500 Etf (SPY)
Apricus Biosciences
Tuanche Ads
Recon Technology Cl A (RCON)
Biora Therapeutics Ord (BIOR)
Akari Therapeutics Adr
Tonix Pharmaceuticals Hldg (TNXP)
Reviva Pharmaceutcls Hldgs I Put Option
Reviva Pharmaceutcls Hldgs I Call Option
Nisun Intl Ent Dvpmt Gp SHS (NISN)
Integrity Applications (GCTK)
Dogness Intl Corp Cl A

View all positions for Sabby Management

Top funds holding Brainstorm Cell Therapeutics call

Group One Trading
Simplex Trading

View all funds holding Brainstorm Cell Therapeutics call